Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sanofi-Aventis (NYSE: SNY) Upgraded by Zacks Investment Research to “Outperform”
Sanofi-Aventis (NYSE: SNY) Upgraded by Zacks Investment Research to “Outperform”
Sanofi-Aventis (NYSE: SNY) Upgraded by Zacks Investment Research to “Outperform”
Submitted by
admin
on December 11, 2010 - 1:01pm
Source:
American Banking Market News
News Tags:
Sanofi
investors
Headline:
Sanofi-Aventis (NYSE: SNY) Upgraded by Zacks Investment Research to “Outperform”
Do Not Allow Advertisers to Use My Personal information
